Section Arrow
HOLX.NASDAQ
- Hologic
Quotes are at least 15-min delayed:2025/09/17 22:00 EDT
Regular Hours
Last
 68.2
+4.87 (+7.69%)
Day High 
70.9 
Prev. Close
63.33 
1-M High
69.03 
Volume 
6.93M 
Bid
67.28
Ask
67.75
Day Low
63.6 
Open
63.74 
1-M Low
63.1923 
Market Cap 
14.09B 
Currency USD 
P/E 26.28 
%Yield -- 
10-SMA 65.61 
20-SMA 66.45 
50-SMA 66.34 
52-W High 84.39 
52-W Low 51.9 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
2.41/4.52
Enterprise Value
16.68B
Balance Sheet
Book Value Per Share
21.77
Cash Flow
Cash Flow Yield
0.07
Income Statement
Total Revenue
2.83B
Operating Revenue Per Share
18.16
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
AVTRAvantor12.4-0.31-2.44%12.58PE
HOLXHologic68.2+4.87+7.69%26.28PE
MBOTMicrobot Medical3.32-0.02-0.60%-- 
BAXBaxter International23.2-0.67-2.81%140.32PE
XRAYDENTSPLY SIRONA13.43-0.19-1.40%-- 
Quotes are at least 15-min delayed:2025/09/17 22:00 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in four segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.